aptamer-based solution to peanut allergies

Frisco-Based Ayass Bioscience Aims to ‘Neutralize’ Peanut Allergies

by | Nov 14, 2024
Researchers at Ayass Bioscience have discovered and developed AYA22A aptamers, molecular compounds that target and bind to peanut proteins that cause most peanut allergy reactions in the U.S. The technology could potentially lead to treatment options for the sensitivity, along with allergy-friendly peanut products and other solutions, the company says.
MORE